Galia Rahav

6PUBLICATIONS
13CO-AUTHORS
Medical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyGreenhouse gas inventories and fluxesCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 09, 2025
Fosmanogepix for the Treatment of Invasive Mold Diseases Caused by Aspergillus Species and Rare Molds: A Phase 2, Open-Label Study (AEGIS).

Michael R Hodges, Margaret Tawadrous, Oliver A Cornely

|Oct 09, 2023
Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia in Patients Treated With Anti-CD20 Monoclonal Antibodies.

Nadav Furie, Michal Mandelboim, Neta Zuckerman

|Aug 19, 2023
Clinical safety and efficacy of novel antifungal, fosmanogepix, for the treatment of candidaemia: results from a Phase 2 trial.

Peter G Pappas, Jose A Vazquez, Ilana Oren

|Oct 26, 2022
First report of myocarditis in two patients with COVID-19 Omicron variant: case report.

Boris Fishman, Orly Goitein, Anat Berkovitch

|Jun 20, 2022
Hospitalized Patients With Severe Coronavirus Disease 2019 During the Omicron Wave in Israel: Benefits of a Fourth Vaccine Dose.

Tal Brosh-Nissimov, Khetam Hussein, Yonit Wiener-Well

|Aug 18, 2017
The plasmid-encoded Ipf and Klf fimbriae display different expression and varying roles in the virulence of Salmonella enterica serovar Infantis in mouse vs. avian hosts.

Gili Aviv, Laura Elpers, Svetlana Mikhlin

Pageof 1

Frequent Collaborators

2 joint publications

George R Thompson

1 joint publications

Gili Aviv

1 joint publications

Laura Elpers

1 joint publications

Michael Hensel